[China Biologic Products Reports Higher Results for the First Quarter 2012 Beijing, China, May 8, 2012 – China Biologic Products, Inc. (NASDAQ: CBPO) (“China Biologic” or the “Company”), one of the leading plasma-based biopharmaceutical companies in the People’s Republic of China (“PRC”), today reported higher financial results for the three months ended March 31, 2012 compared with the first quarter] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building (+86) 10-6598-3111 ____________________________________________________________ (Former name or former address, if changed since last report) see ITEM 2.02 RESULTS OF]